Galectin Therapeutic (GALT) gains 0.24% for May 20

Equities Staff  |

Galectin Therapeutic (NASDAQ: GALT) shares gained 0.24% to end trading Thursday at $4.21 per share - a net change of $0.01. Shares traded between $4.38 and $4.11 throughout the day.

405394 shares of Galectin Therapeutic exchanged hands.

Visit Galectin Therapeutic’s profile for more information.

About The Nasdaq Stock Market

The Nasdaq Stock Market is a global leader in trading data and services, and equities and options listing. Nasdaq is the world's leading exchange for options volume and is home to the five largest US companies - Apple, Microsoft, Amazon, Alphabet and Facebook.

To get more information on Galectin Therapeutic and to follow the company’s latest updates, you can visit the company’s profile page here: Galectin Therapeutic’s Profile. For more news on the financial markets be sure to visit Equities News. Also, don’t forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Chart is provided by TradingView based on 15-minute-delayed prices. All other data is provided by Barchart as of 4:30pm ET on the day of publication.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Trending Articles

Online Sales Declined on Black Friday and Cyber Monday for First Time
Profiting From Energy Efficient Cryptocurrency Mining
Is AI Ready for Prime Time: Jeff Kagan
Stocks Close Broadly Lower as Powell Signals Faster Tapering by Fed
UK Regulator Rules Facebook Must Sell Giphy
US Bank Profits Slip 1.2% in Q3
Omicron Variant Reached Europe Earlier Than Previously Thought
Vaccine Stocks Soar Amid Omicron-Related Volatility



Market Movers

Sponsored Financial Content